The revised EBM catalog came into force in Germany since July 2020

27

Jul 2020

The revised EBM (German Uniform Evaluation Standard) catalog came into force on July 1, 2020. MTRC has compiled the selection of the most significant changes.

The reimbursement of services in the public outpatient sector in Germany is regulated in the EBM catalogue (Einheitlicher Bewertungsmaßstab), updated once in a quarter (4 times a year). The adaption time frame of the EBM catalogue for a specific code is around five years but varies depending on the evidence.

The list of the most important changes in EBM for the third quarter of 2020 is presented below:

  • Endoscopic single-use instruments
    • The fee order item (GOP) 40460 "Flat rate in connection with the performance of the service according to fee order items 01742, 04515, 04520, 08334, 13260, 13401, 13402, 13423 and 30601 when using a single-use high-frequency diathermy snare for a polypectomy or a mucosectomy" with a tariff of €12.00 was added
    • GOP 40461 "Flat rate in connection with the performance of the service according to the fee order items 01741, 04511, 04514, 08311, 09315, 09317, 13400, 13421, 13422, 13430, 13662, 26310 and 26311 when using a single-use sampling device" with a tariff of €8.00 was added
    • GOP 40462 "Flat fee in connection with the performance of the service under fee order items 01742, 04511, 13400 and 13423 when using a clip including a single-use endo / hemo clip applicator", per clip with a tariff of €20.80 was added
  • Kidney replacement therapy
    • The GOPs 04567 "Surcharge in connection with fee order item 04562" and 13603 "Surcharge in connection with fee order item 13602" for continuous care for a patient requiring dialysis in children and adults correspondingly with a tariff of €13.18 were added
  • Psychotherapeutic treatment for adults in the form of systemic therapy
    • The GOPs 35431 "Systemic therapy (short-term therapy 1, individual treatment)", 35432 "Systemic therapy (short-term therapy 2, individual treatment)" and 35435 "Systemic therapy (long-term therapy, individual treatment)" with a tariff of €101.30 were added
    • The GOPs 35703 "Group therapy with 3 participants" with a tariff of €100.64, 35704 "Group therapy with 4 participants" with a tariff of €84.82, 35705 "Group therapy with 5 participants" with a tariff of €75.37, 35706 "Group therapy with 6 participants" with a tariff of €69.00, 35707 "Group therapy with 7 participants" with a tariff of €64.38, 35708 "Group therapy with 8 participants" with a tariff of €61.09 and 35709 "Group therapy with 9 participants" with a tariff of €58.45 were added
  • Reimbursement of trial procedures in accordance with section 137e SGB V. The following sub-chapters were included in the EBM:
    • 61.1 "Trial guideline "Liposuction" with 19 new GOPs
    • 61.2 "Trial guideline "Tonsillotomy" with 12 new GOPs
    • 61.3 "Trial guideline "MRgFUS-TUF" concerning magnetic resonance image-controlled, highly focused ultrasound therapy for the treatment of uterine fibroids with three new GOPs
    • 61.4 "Trial guideline "MM-pul-art-Druck-Herzinsuff" concerning the measurement and monitoring of pulmonary artery pressure using an implanted sensor to optimize therapy for heart failure in stage NYHA III with five new GOPs.

The latest version of EBM can be accessed here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

22

Jun 2021

In late May 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, has published Bulletins 0177 and 0074 with changes to be implemented not later than August 01, 2021. Five new procedure codes related to diagnostic imaging, ENT, breast reconstruction, and gynecology, and nine new diagnostic codes were introduced.

Read more

21

Jun 2021

On June 16, 2021, the Institute for Quality and Efficiency in Health Care (IQWiG) has opened the submission period for proposals for topics of the health technology assessment (HTA) reports to be developed in 2022.

Read more

14

Jun 2021

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May 2021. Recommendations concern orthopedic devices, cardiovascular, peripheral vascular, and neurovascular devices, medical aids, and pulmonary artery pressure sensor.

Read more

09

Jun 2021

For the first time in three years, the Institute for Quality and Efficiency in Health Care (IQWiG) received data within the framework of the early benefit assessment of new examination and treatment methods (NUB) with high-risk medical devices according to §137h of Social Code Book (SGB) V. This involves seven invasive therapeutic cardiovascular, pulmonary, neurological, gastrointestinal, and urological procedures.

Read more

31

May 2021

The application portal for inclusion in the Health App Directory at the Federal Office for Drugs and Medical Devices (BfArM) in Germany has been online since May 27, 2020. The first reimbursable health apps were introduced on the Directory in early October 2020. As of May 27, 2021, a total of 74 applications were received, 51 of which for provisional listing and 23 for final listing. Fifteen applications (20%) were introduced on the Directory.

Read more